Author: Jeffrey P. Staab, MD, MS
Editorial changes - 2009-10-13
Author information and module status
Posttraumatic Stress Disorder
Select a section to view guidance statement information on Posttraumatic Stress Disorder.
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools
What's New
ACP Members can access the full PIER website.

Newly Cited Reference2008-01-01
Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence.
New Reference of Interest2009-08-05
Asthma and posttraumatic stress symptoms 5 to 6 years following exposure to the World Trade Center terrorist attack.
FAQs
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline, Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.